Update on patient safety

British Journal of Ophthalmology

Volumn 95, Issue 9, 2011, Pages 1183-1184

  Kelly, Simon P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATARACT EXTRACTION; CLINICAL PRACTICE; EDITORIAL; EYE SURGERY; GLAUCOMA; HUMAN; INCIDENT REPORT; PATIENT SAFETY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; THERAPY DELAY; WET AGE RELATED MACULAR DEGENERATION;

HUMANS; MACULAR DEGENERATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; QUALITY OF HEALTH CARE; SAFETY; UNITED STATES;

EID: 80052118320     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300538     Document Type: Editorial

References (15)

1. National Patient Safety Agency. Building A Memory: Preventing Harm Reducing Risks Improving Patient Safety, 2005. http://www.nrls.npsa.nhs.uk/ resources/?entryid45=59797.
2. NICE guidance CG85. Glaucoma: Diagnosis AND Management Of Chronic Open Angle Glaucoma And Ocular Hypertension, 2009. http://guidance.nice.org.uk/CG85.
3. National Patient Safety Agency. Delayed Appointments Can Lead To Blindness: 2009 Rapid Response Report, 2009. NPSA/2009/RRR004. Gateway reference: 11994. http://www.nrls.npsa.nhs.uk/resources/type/alerts/?entryid45= 61908.
4. NICE Quality Standard: Glaucoma in Adults, 2011. http://www.nice.org.uk/ guidance/qualitystandards/qualitystandards.jsp.
5. Kelly SP, Jalil A. Wrong intraocular lens implant; learning from reported patient safety incidents. Eye (Lond) 2011;25:730-4. doi:10.1038/eye.2011.22. http://www.nature.com/eye/journal/vaop/nCurrent/full/eye201122a.html.
6. Surgical Safety Checklist: for Cataract Surgery Only. London: National Patient Safety Agency, 2010. http://www.nrls.npsa.nhs.uk/resources/clinical- specialty/ophthalmology/?entryid45=74132.
7. World Health Organization. Safer Surgery Saves Lives Newsletter, 2010. http://www.who.int/patientsafety/safesurgery/sssl-newsletter-aug-2010.pdf.
8. Kelly SP, Astbury N. Patient safety in cataract surgery, locking the Luer lock. Eye 2007;21:449. (Pubitemid 46358831)
9. National Institute for Health and Clinical Evidence. NICE Technology Appraisal Guidance TA155, Ranibizumab And Pegaptanib for the Treatment of Age-Related Macular Degeneration. London: National Institute for Health and Clinical Evidence, 2008. http://www.nice.org.uk/nicemedia/pdf/TA155guidance.pdf.
10. Amoaku W. Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment. Eye 2009;23:2140-2.
11. Kelly SP, Barua A. A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications. Eye (Lond) 2011;25:710-16. doi:10.1038/eye.2011.89. http://www.nature.com/eye/journal/vaop/ ncurrent/full/eye201189a.html.
12. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials. TAP report number 2. Arch Ophthalmol 2001;119:198e207. (Pubitemid 32147926)
13. Tey A, Lyall D, Foot B, et al. Post Intravitreal anti-VEGF Endophthalmitis (PIAE) in the United Kingdom: Incidence, Features and Outcomes. Birmingham: Royal College of Ophthalmologists Annual Scientific Congress, 2011. Conference Abstract.
14. The Royal College of Ophthalmologists. Patient Safety in Ophthalmology. London: The Royal College of Ophthalmologists, 2011. http://www.rcophth.ac.uk/ core/core-picker/download.asp?id=852&filetitle= Patient+Safety+in+Ophthalmology+February+2011.
15. Department of Health. Review of Arm's Length Bodies to Cut Bureaucracy. London: Depart of Health, 2010. http://www.dh.gov.uk/en/MediaCentre/ Pressreleases/DH-117844.